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Abstract
Sox2 is a key component of the transcription factor network that maintains the pluripotent state of embryonic stem cells
(ESCs). Sox2 is regulated by multiple post-translational modifications, including ubiquitination, sumoylation, acetylation and
phosphorylation. Here we report that Sox2 is in association with and methylated by coactivator-associated arginine
methyltransferase 1 (CARM1), a protein arginine methyltransferase that plays a pivotal role in ESCs. We found that CARM1
facilitates Sox2-mediated transactivation and directly methylates Sox2 at arginine 113. This methylation event enhances
Sox2 self-association. Furthermore, the physiological retention of Sox2 on chromatin restricts the Sox2 methylation level.
Our study reveals the direct regulation of Sox2 by CARM1 that sheds lights on how arginine methylation signals are
integrated into the pluripotent transcription factor network.
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Introduction
As a member of the Sox (SRY-related HMG box) protein
family, Sox2 is required for normal embryogenesis [1]. Embryonic
stem cells (ESCs), derived from the inner cell mass of an early
embryo, are capable of generating all the somatic cell types, and
Sox2 is one of the core transcription factors that maintain the
pluripotent state of ESCs [2]. Sox2 directly controls the expression
of a large number of pluripotency-related genes, such as oct3/4,
nanog, fgf4 and utf1 [3].
Sox family members are known to be tightly regulated by post-
translational modifications [4]. Recent findings indicated that
ubiquitination, sumoylation, acetylation and phosphorylation
regulate Sox2 at multiple levels, including subcellular localization,
DNA binding, and protein stability [5,6,7].
Among the various types of protein post-translational modifi-
cations, the methylation of arginine residues is catalyzed by a
family of protein arginine methyltransferases (PRMTs) [8].
PRMT4/CARM1 catalyzes the asymmetric di-methylation of
arginine residues in a variety of proteins, including histones and
certain key transcription factors, and acts as a coactivator for
transactivation [8]. CARM1 deficient mice are small in size, low in
birth rate and die perinatally [9]. Moreover, overexpression of
CARM1 at the two-cell-stage directs the blastomeres to contribute
to the pluripotent inner cell mass, and the ESCs with depleted
CARM1 gradually lose their pluripotency [10,11]. However, the
details describing how CARM1 modulates pluripotency mainte-
nance and early embryonic development remain unclear.
In this work, we indicate that CARM1 facilitates Sox2-mediated
transactivation and methylates Sox2 at Arg113. We also show that
methylated Sox2 is more prone to self-associate than its
unmethylated counterpart. In addition, the methylation level of
Sox2 is restricted by the tight association of Sox2 with chromatin.
Our data suggest a direct relationship between arginine methyl-
ation and Sox2 function.
Results
CARM1 is associated with Sox2
Because CARM1 is required for the identity maintenance of
ESCs, we supposed that CARM1 might directly regulate the core
pluripotent transcription factor network. To verify this hypothesis,
we first examined the interaction of CARM1 with Sox2, one of the
most critical transcription factors during embryogenesis [1]. As
shown in Fig. 1A, CARM1 can be co-immunoprecipitated by Sox2.
Then we asked whether endogenous CARM1 is in association with
Sox2. Both fgf4 and utf1 are typical Sox2 target genes [3], therefore,
we used two biotin-labeled DNA probes, covering the Sox2-binding
sites in fgf4 and utf1 respectively, to enrich endogenous Sox2 from
P19 embryonal carcinoma cells [12,13]. As indicated in Fig. 1B,
endogenous Sox2 was sufficiently enriched by both DNA probes,
and CARM1 can be co-precipitated. Next, we analyzed domain
specificity of CARM1 to interact with Sox2. We generated GST-
fused truncation proteins of CARM1. By performing GST pull-
down assays, we found that the methyltransferase domain in the
middle of CARM1 is efficient in mediating its interaction with Sox2
(Fig. 1C and D). Similarly, we found that both the HMG-box and
C-terminal of Sox2 can mediate the interaction between Sox2 and
CARM1 (Fig. 1E and F).
CARM1 facilitates Sox2-mediated transactivation
To investigated the impact of CARM1 on Sox2-meditated
transactivation, we constructed a Sox2 reporter plasmid 86S/O-
luc (Supporting information Figure S1), that can be efficiently
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inhibited the reporter gene expression driven by Sox2 (Fig. 2A),
while the overexpression of CARM1 dramatically enhanced the
reporter activity (Fig. 2B). We also checked the reporter gene
expression in MCF7 cells treated with a methyltransferase
inhibitor adenosine dialdehyde (AdOx) and showed that inhibition
of methylation reduced Sox2-mediated transactivation (Fig. 2C).
In addition, we overexpressed CARM1 in pluripotent P19 cells,
and found that several pluripotency-related genes were upregu-
lated at the mRNA level (Supporting information Figure S2), while
knockdown of CARM1 reduced the expression of these genes
(Supporting information Figure S3). We next examined whether
the facilitation of Sox2 transactivity by CARM1 relies on its
catalytic activity. As reported that R169A substitution of CARM1
causes a complete loss of its methyltransferase activity [15], which
is also confirmed in our 86S/O-luc reporter assays that it was
more active in the cells co-expressing Sox2 and wild-type CARM1
than those of Sox2 and CARM1 with R169A mutation (Fig. 2D).
CARM1 methylates Sox2
Because of the association of CARM1 with Sox2, we
investigated whether Sox2 could be methylated by CARM1. As
shown in Fig. 3A, Sox2 can be methylated by GST-tagged
CARM1, and PRMT1, 3 and 5. Sox2 proteins methylated by
PRMT1 and CARM1 were analyzed by mass spectrometry.
Arginine residues Arg90, Arg98, Arg113 and Arg115 were
identified as target sites for PRMT1, and Arg113, Arg115, and
Arg116 were identified for CARM1 (Fig. 3B and Supporting
information Figure S4). To confirm the mass spectrometry data,
these five arginine residues were mutated to lysine (R to K)
individually or in combination (Fig. 3B). In addition, FLAG-
tagged PRMTs, immunoprecipitated from the whole cell extracts
of HEK293T cells, were used to mimic their respective physi-
ological substrate specificity. We found that FLAG-PRMT4/
CARM1 methylated GST-Sox2 and the methylation level was
only slightly reduced by a single mutation of Sox2 at Arg90 (mut-a)
or at Arg98 (mut-b), however, Sox2 methylation was abolished by
combined substitution of Arg113, Arg115, and Arg116 (mut-c)
(Fig. 3C). Moreover, we found that immunoprecipitated CARM1
mutants were unable to methylate Sox2 at all, we thereby
conclude that the methylation of Sox2 by CARM1 is dependent
on the catalytic activity of CARM1 (Fig. 3D). By the respective
substitutions to lysine, we demonstrated that Arg113, but not
Arg115 or Arg116, is crucial for CARM1-mediated Sox2
methylation (Fig. 3E). These data suggest that CARM1 methylates
Sox2 preferentially at Arg113.
Figure 1. CARM1 is in association with Sox2. (A) Co-immunoprecipitation of Sox2 with CARM1. Whole cell extracts (WCEs) of MCF7 cells
transfected with (+) or without (-) FLAG-CARM1 or GFP-Sox2, were subjected to immunoprecipitation with anti-FLAG antibody and blotted with
antibodies against GFP or FLAG. (B) Co-precipitation of endogenous CARM1 with Sox2 by DNA pull-down. Biotin-labeled probes covering Sox2-
binding sites in fgf4 and utf1 respectively were incubated with WCEs of P19 cells and streptavidin-conjugated agarose beads. The proteins
precipitated with beads were denatured and resolved in SDS-PAGE and detected by immunoblotting with antibodies against Sox2 or CARM1. NC:
negative control, no probe added. (C) Schematic drawing of the wild type and truncated CARM1 fragments. (D) GST pull-down assays to detect the
interaction of Sox2 with CARM1 derivates. GST or GST-Sox2 was first incubated with WCEs of HEK293T cells ectopically expressing FLAG-CARM1
derivates. The GST pull-down products were immunoblotted with anti-FLAG antibody. Input: WCE control. (E) Schematic drawing of the wild type and
truncated Sox2 fragments. (F) The interaction of Sox2 derivates with CARM1 in GST pull-down assays. GST or GST-Sox2 derivates were first incubated
with whole cell extracts (WCEs) of HEK293T cells ectopically expressing FLAG-CARM1. The GST pull-down products were immunoblotted with anti-
FLAG antibody.
doi:10.1371/journal.pone.0027026.g001
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a polyclonal antibody against methylated Sox2 in rabbit. This
antibody specifically recognized the Sox2 peptide asymmetrically
di-methylated at Arg113, but not the unmethylated Sox2 peptide
(Supporting information Figure S5). By co-expression of Sox2 with
CARM1 in MCF7 cells, we found that the recognition of wild-type
Sox2 by the anti-methyl-Sox2 antibody was promoted by enzy-
matically active CARM1. In contrast, CARM1 did not enhance
the methylation level of Sox2 with combined mutations of R113/
R115/R116 (Fig. 3F).
Next,we treated P19 cellswithAdOxto investigate its effect onthe
methylation of endogenous Sox2. AdOx treatment clearly reduced
the recognition of endogenous Sox2 by the anti-methyl-Sox2
antibody, we thereby deduced that endogenous Sox2 is methylated
at Arg113 (Fig. 3G). To explore whether CARM1 accounts for the
methylation of endogenous Sox2, CARM1 was knocked down or
overexpressed in P19 cells, and Sox2 methylation level was detected.
As shown in Fig. 3H, while CARM1 depletion led to a reduction in
Sox2 methylation, its overexpression was accompanied by an
increased methylation level on Sox2 (Fig. 3J). These data indicate
that CARM1-mediated the methylation of Arg113 in Sox2.
The impact of CARM1-mediated methylation on Sox2
self-association
It has been reported that several Sox proteins form homo- or
heterodimer complexes that lead to different functional outputs
and that Sox2 can self-associate through its HMG-box [16]. Here,
we examined the effect of methylation on Sox2 self-association. As
indicated in Fig. 4A, co-expression of wild-type Sox2 with
CARM1 not only increased Sox2 methylation, but also promoted
the interaction between FLAG-Sox2 and GST-Sox2. However,
the affinity of FLAG-Sox2-mut-c to GST-Sox2 was less sensitive to
the co-existence of CARM1.
Sox2 possesses two nuclear localization signals [17] and residue
Arg113 is within NLS2 (Supporting information Figure S6).
Therefore, we postulated that CARM1-mediated Sox2 methyla-
tion is related to NLS2 function. To augment this assumed
modulation of NLS2 by methylation, Sox2 NLS1 was perturbed
(mNLS1). Sox2-mNLS1 had an obvious distribution in the
cytoplasm, whereas wild-type Sox2 localized to the nucleus
predominantly (Fig. 4B). By analyzing the Sox2 distribution in
subcellular fractions, we found that neither the R113K mutation
nor the co-expression of CARM1 had obvious effect on the
subcellular localization of GFP-Sox2-mNLS1 (Fig. 4C).
We also explored whether CARM1 affects Sox2 protein
stability. GFP-Sox2-mNLS1 was expressed alone or in combina-
tion with CARM1 in MCF7 cells, and the cells were treated with
cycloheximide (CHX) to inhibit de novo protein synthesis. As
indicated in Fig. 4D, overexpression of CARM1 enhanced Sox2
methylation with no obvious change on its degradation.
These results suggest that Arg113 methylation promotes Sox2
self-association but does not affect Sox2 subcellular localization or
degradation.
The role of NLS1 in Sox2 methylation
Because CARM1 localizes primarily to the cytoplasm and Sox2-
mNLS1 displays an increased co-localization with CARM1 in
MCF7 cells (Fig. 5A), which inspired us to examine whether Sox2
Figure 2. CARM1 facilitates Sox2 transactivation activity. (A) The effect of CARM1 knockdown on Sox2 mediated reporter activity assay. FLAG-
Sox2 and the luciferase reporter plasmid (86S/O-Luc) were co-transfected into MCF7 cells with either the plasmid of RNAi vector or siCARM1. (B) The
effect of CARM1 overexpression on Sox2-mediated reporter activity. Wild-type Sox2 and its expression vector were individually transfected into MCF7
cells with or without FLAG-CARM1. (C) The effect of AdOx on Sox2-mediated reporter activity. MCF7 cells were first transfected with the 86S/O-Luc
reporter and FLAG-Sox2 for 24 hours. The cells were then treated with different concentrations of AdOx as indicated for another 24 hours before
harvest for reporter activity assay. (D) The effect of CARM1-WT and CARM1-R169A overexpression on Sox2-mediated reporter activity. Wild type and
truncated Sox2 (as shown in Fig. 1E) and its vector were individually transfected into MCF7 cells with CARM1-WT or CARM1-R169A. Each bar
represents mean value 6 S.D. from at least three independent experiments. ** P,0.01, Student’s t-test.
doi:10.1371/journal.pone.0027026.g002
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perturbation of NLS1 significantly enhanced Sox2 methylation
(Fig. 5B). Unexpectedly, we found that NLS1 dysfunction
abolished the chromatin association of Sox2 (Fig. 5C). Consis-
tently, Sox2-mNLS1 completely lost the ability to activate the
86S/O-luc reporter (Fig. 5D). Wild-type Sox2 stringently co-
localizes with DNA (Fig. 5E). After cells were permeabilized as
described [18], wild-type Sox2 was still tightly attached to
chromatin with no obvious diffusion; however, most of the
Sox2-mNLS1 proteins diffused out of the cells in less than thirty
seconds (Fig. 5F). Therefore, the physiological retention of Sox2
on chromatin restricts its free movement, and might consequently
limit its nuclear-cytoplasm exchange and contact with CARM1.
These results suggested that the chromatin retention of Sox2
restricts CARM1-mediated Sox2 methylation.
Discussion
In this work we demonstrate that CARM1 is in association with
Sox2 and facilitates Sox2-mediated transactivation. We identify
Sox2 as a novel substrate for CARM1. Methylated Sox2 has
increased self-association, but displays no obvious change in
protein stability or subcellular localization. However, the Sox2
methylation level is restricted by the tight association of Sox2 with
chromatin.
CARM1 has been shown to act as a coactivator of a number of
transcription factors through direct modification of histone
arginines, and subsequently, it increases local chromatin accessi-
bility for transcriptional machinery [19]. This impelled us to
assume that Sox2 might also recruit CARM1 to its target genes to
modulate the chromatin architecture. Consistent with this
Figure 3. CARM1 methylates Sox2. (A) Methylation assays indicating methylation of Sox2 by PRMTs. Methylation signals were detected by
fluorography. Total GST-Sox2 (arrowhead) and GST-PRMTs (asterisks) are shown by Coomassie brilliant blue staining. (B) The schematic representation
of Sox2 methylation sites that are identified by mass spectrometry analysis. The sequence constitution of Sox2 mutants is shown, candidate
methylation sites are underlined, and the substitutional lysine residues are in bold. (C and E) Methylation assays show Arg113 of Sox2 is the primary
CARM1-methylated site. FLAG-tagged CARM1 was ectopically expressed in HEK293T cells and immunoprecipitated with anti-FLAG antibody. Equal
amounts of FLAG-CARM1 immunoprecipitates were incubated with GST-Sox2 derivatives in the presence of [
3H]-SAM. (D) Methylation assays
indicating methylation of Sox2 by CARM1. FLAG-CARM1 and FLAG-CARM1-R169A were ectopically expressed in HEK293T cells and
immunoprecipitated with anti-FLAG antibody. Equal amounts of FLAG-CARM1 and FLAG-CARM1-R169A immunoprecipitates were incubated with
GST-Sox2 and GST-Sox2-mut-c in the presence of [
3H]-SAM. Methylation signals were detected by fluorography. FLAG-CARM1 and FLAG-CARM1-
R169A were detected with anti-FLAG antibody. Total GST-Sox2 or GST-Sox2-mut-c are shown by Coomassie brilliant blue staining. (F) Methylation of
FLAG-Sox2 in MCF7 cells. Wild-type and mut-c of FLAG-Sox2 were overexpressed in MCF7 cells together with FLAG-CARM1 or FLAG-CARM1-R169A.
Sox2 methylation at Arg113 was detected with anti-methyl-Sox2 antibody. (G) Methylation of endogenous Sox2 in P19 cells treated with AdOx. P19
cells were treated with AdOx for 24 hours. Sox2 methylation levels were detected with anti-methyl Sox2. (H) The effect of CARM1 knockdown with
siCARM1 plasmid on Sox2 methylation in P19 cells. (J) The effect of CARM1 overexpression on Sox2 methylation in P19 cells. Myc-CARM1 (+) or Vector
(-) were transfected into P19 cells and the Sox2 methylation levels were detected.
doi:10.1371/journal.pone.0027026.g003
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especially enriched at the promoters of several key Sox2 target
genes in ESCs [11]. Indeed, our data indicate that CARM1
interacts with Sox2 and enhances Sox2-mediated transactivation.
The structure of the HMG box and the residues flanking
methylation site of Sox2 are conserved among Sox family
members (Supporting information Figure S7) [20]. Recently,
CARM1 was reported to methylate Sox9, a Sox family member
implicated in chondrogenesis and sex determination [21].
Therefore, it is reasonable to hypothesize that the CARM1-
mediated arginine methylation is a prevalent modulation mech-
anism throughout the Sox family.
Sox2, Oct3/4 and Nanog co-occupy a series of target genes that
are discriminately expressed in ESCs [2]. Moreover, Sox2 plays
indispensable roles at multiple stages of embryogenesis [22].
Consistently, Sox2 modulates different target gene groups by
synergistic action with distinct partners [23]. Given the increased
self-association of methylated Sox2, it would be interesting to
identify protein profiles that associate with Sox2, and particularly
with methylated Sox2, at different developmental stages.
Another key pluripotent transcription factor, Oct3/4, is also
subjected to multiple post-translational modifications [24]. Due to
the essential role of PRMTs in embryonic development [25], it is
reasonable to suggest that numerous transcription factors and
regulatory proteins involved in pluripotency maintenance are
potential targets for arginine methylation. We expect that the
further proteomic identification of PRMT-associated proteins and
arginine methylation substrates in pluripotent cells would shed
light on the mechanism of PRMTs-mediated modulation of early
embryogenesis.
Materials and Methods
Cell culture and treatment
Human breast cell line MCF7 and mouse embryonal carcinoma
cell line P19 were purchased from Cell Resource Center, IBMS,
CAMS/PUMC. MCF7 cells were maintained in DMEM
containing 10% fetal calf serum. P19 embryonal carcinoma cells
were maintained in alpha MEM supplemented with 10% fetal calf
serum. Differentiation of P19 cells was induced with 0.5 mMo f
retinoic acid as described [13].
Plasmid, constructs, transfections and Reporter Gene
Assays
To obtain the 86(S/O)-luciferase reporter construct, four
copies of annealed oligonucleotides containing two fgf-4 enhancer
elements [14] were tandemly inserted into the pGL3-promoter
plasmid digested with XhoI and NotI, as indicated in Supporting
Figure 4. The effects of Arg113 methylation on Sox2 self-association, subcellular localization and protein stability. (A) The effect of
CARM1-mediated Sox2 methylation on Sox2 self-association. FLAG-Sox2 wild-type and mutant-c were expressed together with (+) or without (-)
FLAG-CARM1 in MCF7 cells. WCEs were immunoblotted to examine the Sox2 methylation level. The remaining lysates were subjected to pull-down
assays with bacterially expressed GST-Sox2 protein. (B) Localization of wild-type and R113K mutant GFP-tagged Sox2 in MCF7 cells. (C) The impact of
CARM1-mediated methylation on the GFP-Sox2-mNLS1 distribution in cell fractions. GFP-tagged Sox2-mNLS1 with or without R113K substitution was
expressed in MCF7 cells, and cell fractions were prepared to detect Sox2 distribution. CE: cytoplasmic extracts; nucleosol: soluble nuclear materials.
(D) The effect of CARM1 on GFP-Sox2-mNLS1 protein stability. GFP-Sox2-mNLS1 and GFP-Sox2-mNLS1-R113K were expressed in MCF7 cells to
examine the effect of CARM1 on Sox2 degradation. Forty-eight hours later, cells were treated with cycloheximide (CHX) as indicated, and Sox2
protein levels were analyzed by immunoblotting assays.
doi:10.1371/journal.pone.0027026.g004
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expression plasmids was conducted according to Stratagene’s
protocol (Stratagene QuikChange Site-directed Mutagenesis kit).
The FLAG-CARM1 expression plasmid was a gift of Dr. Xu Wei.
The CARM1 RNAi construct siCARM1 was generated by
subcloning double-stranded oligomers into the BbsI digested
pBabe-Dual vector [26] (forward 59-AAAGTCCAGTAACCTC-
CTGGAT-39; reverse 59-AAAAATCCAGGAGGTTACTGGA-
39). The Sox2 coding sequence was subcloned into EGFP-C1 to
construct GFP-Sox2. Myc-CARM1 was constructed by the
insertion of the CARM1 CDS into pCMV-tag-3B.
Cells were transfected using the Vigofect reagent (Vigorous,
China) in accordance with the manufacturer’s instructions.
For the firefly luciferase activity analysis, the CMV-Renilla
plasmid was used as an internal control to normalize for
transfection efficiency. The statistical significance (P value) was
calculated by unpaired Student’s t-test.
For CARM1 knock down in P19 cells, nineteen base-pair of
oligo-RNA segments (sense, 59-GGAUAGAAAUCCCAUUCAA-
dTdT-39, antisense, 59-UUGAAUGGGAUUUCUAUCCdTdT-
39) were transfected with Lipofectamine 2000 (Invitrogen) into P19
cells. The cells were harvested after 36 hours for RNA extraction.
Quantitative Real-Time RT-PCR analysis
Total RNA was purified with Trizol reagent (Invitrogen)
according to the manufacturer’s instructions. One microgram of
total RNA was used for cDNA synthesis with a Reverse
transcription kit (Invitrogen). Quantitative real-time PCR was
performed using the ExTaq Mix kit (Takara), and the primer
sequences used are listed as follow: (F; forward; R; reverse.)
Sox2, F: TCCATGACCAGCTCGCAGA; R: GAGGAAGA-
GGTAACCACGGG
Oct3/4, F: TCACTCACATCGCCAATCA; R: GTAGCCT-
CATACTCTTCTCGTT
Nanog, F: GGCAGCCCTGATTCTTCTAC; R: CGCTTG-
CACTTCATCCTTT
Lin28, F: CGGCCAAAAGGGAAGAACAT; R: CATTCCT-
TGGCATGATGGTCT
Fgf4, F: GGCTTCGGCGGCTCTACT; R: AGGATTCGTA-
GGCGTTGTAGTTG
Figure 5. The role of NLS1 in CARM1-mediated Sox2 methylation. (A) Wild-type and mNLS1 of GFP-Sox2 were overexpressed in MCF7 cells
together with FLAG-CARM1. Red, CARM1 immunostained with anti-FLAG antibody; green, GFP-Sox2; blue, DNA. Upper panel: GFP-Sox2-wt; lower
panel: GFP-Sox2-mNLS1. (B) The impact of the NLS1 mutation on Sox2 methylation. (C) The distribution of Sox2 derivatives in MCF7 cell fractions. CE:
cytoplasmic extracts; nucleosol: soluble nuclear materials; chromatin: extracts from unsoluble chromatin pellets with 500 mM NaCl. (D)
Transactivation activity of GFP-Sox2-mNLS1 in MCF7 cells. The wild-type GFP-Sox2 was used as a control. ** P,0.01, Student’s t-test. (E) Tight
association of Sox2 with chromatin in MCF7 cells. Left: The subcellular localization of wild-type GFP-Sox2; right: GFP-Sox2 bound to chromosomes in
mitosis (picture at the bottom indicates the overlap of GFP-Sox2 and the background under bright field microscopy). (F) Chromatin retention of GFP-
Sox2. MCF7 cells expressing GFP-Sox2-wt or GFP- Sox2-mNLS1 were permeabilized with 0.3% NP-40. Sequential images were captured before and
after permeabilization.
doi:10.1371/journal.pone.0027026.g005
Sox2 Is Methylated by CARM1
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e27026Utf1, F: TCCTCTTACGAGCACCGACAC; R: GCAACGC-
GGTATTCAACGA
CARM1, F: TGTGGCTGGAATGCCTACTG; R: TTGGA-
CAATGCCCGTGCT
GAPDH, F: GAAGGTGAAGGTCGGAGTC; R: GAAGAT-
GGTGATGGGATTT
Preparation of GST-fusion proteins, methylation assays
and mass spectrometry analysis
Protein coding sequences of PRMTs and Sox2 were inserted
into the pGEX-6p-1 plasmid individually, and GST-fusion pro-
teins were expressed in E. coli BL21 and purified as per
Pharmacia’s instructions. Methylation assays were performed as
described [27]. Briefly, each GST-PRMT was mixed with its
respective substrate in 1x methyltransferase buffer (50 mM Tris
[pH 8.0], 1 mM PMSF, 0.5 mM DTT) along with 1 mCi of
[
3H]S-adenosylmethionine (SAM) or unlabeled 100 mM SAM and
brought up to a total reaction volume of 50 ml. Reactions were
incubated at 30uC for one hour. Samples were resolved by SDS-
PAGE and stained with Coomassie brilliant blue. After destaining,
gels with radioactively labeled samples were visualized by
fuorography with EN
3HANCE (PerkinElmer) according to the
manufacturer’s instructions. Gel bands corresponding to methyl-
ated substrates with unlabeled SAM were excised, cut into small
cubes, digested in-gel with trypsin and subjected to liquid
chromatography-tandem mass spectrometry (LC-MS/MS) analy-
sis (IBP, CAS, Beijing). MS/MS spectra were analyzed using
Bioworks 3.1 software.
Preparation of cell fractions
Fractions of MCF7 cells were prepared as previously described
[28] and partially modified according to Steven Henikoff lab’s
protocol [29]. Briefly, to collect the cytoplasmic extraction, cells
were resuspended in 16 buffer A (10 mM HEPES, pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, 1 mM PMSF,
10 mg/ml aprotinin, 10 mg/ml leupeptin) and left on ice for 5
minutes. NP-40 was added to 0.3%, and samples were imme-
diately pipetted up and down to disrupt cell membranes. Samples
were centrifuged at 500 g for 5 min at 4uC. Supernatants were
then centrifuged at maximum speed (16,000 g) for 15 min at 4uC,
and supernatants were stored as Cytoplasmic Extract ‘CE’.
Nuclei pellets obtained as above were then lysed in 500 ml RIPA
buffer (50 mM HEPES, pH 7.5, 150 nM NaCl, 2 mM EDTA,
2 mM EGTA, 1% TritonX-100, 50 mM NaF, 5 mM sodium
pyrophosphate, 50 mM sodium b-glycerophosphate, 1 mM
sodium ortho-vanadate, 1 mM DTT, 1 mM PMSF, 10 mg/ml
leupeptin, 10 mg/ml aprotinin) for 30 minutes with gentle rota-
tion. Samples were centrifuged at maximum speed (16,000 g) for
15 min at 4uC, and the supernatants were stored as ‘nucleosol’,
mainly containing the physiologically soluble nuclear material.
To obtain the ‘chromatin’ fraction, the pellets from above were
washed twice with RIPA buffer, then resuspended in 500 ml
RIPA buffer (containing protease inhibitors) with NaCl up to
500 mM, and extracted for an hour. The supernatants were then
collected.
GST Pull-down, co-immunoprecipitation,
immunoblotting assays and immunostaining
GST Pull-down, co-immunoprecipitation, immunoblotting and
immunostaining assays were carried out as previously described
[30] with a partial modification. When detecting the interaction
between Sox2 and CARM1, we used 0.2% NP-40 to lyse cells and
wash agarose beads.
Cell permeabilization assays
Cell permeabilization assays were conducted as previously
described [18].
DNA pull-down assays
DNA pull-down assays were performed as previously described
[31]. In brief, 50 nmol 59-end biotin-labeled oligo-DNA probes
covering the Sox2-binding sites in fgf4 or utf1 were incubated with
1 mg whole cell extracts of P19 cells and streptavidin-conjugated
agarose beads (Millipore) overnight at 4uC. Then the beads were
collected and washed five times with lysis buffer and prepared for
SDS-PAGE and detected by immunoblotting. The sequences of
oligo-DNA are indicated as below:
fgf4, sense strand:
biotin-CTGAAAGAAAACTCTTTGTTTGGATGCTAAT-
GGGATACTAAGCTGA;
antisense strand:
biotin-TCAGCTTAGTATCCCATTAGCATCCAAACAAA-
GAGTTTTCTTTCAG.
utf1, sense strand:
biotin-CTGAAAGATGAGAGCCCTCATTGTTATGCTA-
GTGAAGTGCCAAGCTGA;
antisense strand:
biotin-TCAGCTTGGCACTTCACTAGCATAACAATGA-
GGGCTCTCATCTTTCAG.
Antibodies
Antibodies are listed as follows: anti-GFP (MBL, M048-3), anti-
CARM1 (CST, 4438s), anti-FLAG (Sigma, F3165), anti-Gapdh
(Chemicon, MAB374), anti-Lamin-B (Santa Cruz, sc-6216), and
anti-Sox2 (Chemicon, AB5603). A polyclonal rabbit antibody
against di-methylated Arg113 of Sox2 (anti-methyl-Sox2) was raised
using the methylated peptide KEHPDYXYRdi-methylPRRKTKC
(asymmetric di-methylarginines are underlined) and purified using a
peptide-affinity column.
Supporting Information
Figure S1 Schematic representation of 86S/O-luc reporter
plasmid. 86S/O-luc carries eight copies of tandem fgf4 enhancer
elements consisting of neighboring binding sites for Sox2 and
Oct3/4.
(JPG)
Figure S2 The effect of CARM1 overexpression on the
expression of pluripotency-related genes in P19 cells. The relative
mRNA levels of pluripotency markers were normalized to Gapdh.
(JPG)
Figure S3 The effect of CARM1 knockdown with synthesized
siRNA on the expression of pluripotency-related genes in P19
cells. The relative mRNA levels of pluripotency markers were
normalized to Gapdh. Control: scrambled siRNA.
(JPG)
Figure S4 MS/MS spectrum of the Sox2 peptide EHPDY-
KYRdi-methylPR. GST-Sox2 methylated by GST-CARM1 was
digested with trypsin and subjected to LC-MS/MS analysis. The
MS/MS spectrum of a peptide corresponding to residues 106-115
of Sox2 showed that Arg113 was di-methylated. An asterisk
indicates the methylated arginine.
(JPG)
Figure S5 Specifically recognition of Sox2 peptide methylated at
Arg113, by anti-methyl-Sox2 antibody. Un-methylated peptide
KEHPDYXYRPRRKTKC (Arg113 is underlined) designated as
Sox2 Is Methylated by CARM1
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e27026‘R113me0’, and the peptide asymmetrically di-methylated at
Arg113 named as ‘R113me2’ were used in dot blot analysis.
(JPG)
Figure S6 Schematic representation of Sox2 nuclear localization
signals. The key residues of NLSs are underlined, and an asterisk
indicates the identified methylation site Arg113. The residues that
are mutated in Sox2-mNLS1 are also shown.
(JPG)
Figure S7 CARM1-mediated methylation may be a regulation
mechanism shared by certain other Sox family members.
Alignment of Sox members highly conserved in sequences flanking
Arg113 was shown. NLS2 was underlined, Arg113 and its
counterparts in other Sox proteins were pointed out with asterisks,
conserved residues were indicated in shadow.
(JPG)
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